Key result
CD36 receptor expression mediates ox-LDL uptake in atherosclerotic plaques, though decreased expression in humans is also associated with increased coronary heart disease incidence.
Answers are grounded in this paper and cite their sources.
Atherosclerosis is a progressive, chronic inflammation in artery walls. Oxidized low density lipoproteins (ox-LDL) play an important role in atherosclerotic plaque formation. ox-LDL are taken up by macrophages mainly through scavenger receptors, among which CD36 is considered to be the most important. Animal studies have shown that crossing atherogenic mice with a strain lacking the expression of CD36 prevented the development of atherosclerosis despite a diet rich in saturated LCFA. In humans, autopsy studies performed in obese patients have demonstrated increased expression of CD36 receptor on macrophages, comprised within atherosclerotic plaques. Until recently it had been believed that CD36 is a major player in atherosclerosis progression in humans. However, recent studies challenge this conviction, showing increased incidence of coronary heart disease in the subgroup of patients with decreased expression of CD36. This article reviews the role of CD36 receptor in the development of atherosclerosis. The authors also discuss current possibilities to interfere with CD36, their potential benefits and hazards.
No takes yet. Share an insight, caveat, or question.
Choromańska et al. (2017) conducted a review in Atherosclerosis. CD36 receptor expression and modulation was evaluated on Atherosclerosis and coronary heart disease. CD36 receptor expression mediates ox-LDL uptake in atherosclerotic plaques, though decreased expression in humans is also associated with increased coronary heart disease incidence.
Synapse has enriched 10 related papers. Consider them for comparative context: